These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7651364

  • 41. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB, Shaddix SC, Rose LM, Waud WR, Shewach DS, Tiwari KN, Secrist JA.
    Biochem Pharmacol; 2000 Dec 15; 60(12):1925-32. PubMed ID: 11108809
    [Abstract] [Full Text] [Related]

  • 42. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 43. Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine.
    Teodori L, Barlogie B, Drewinko B, Swartzendruber D, Mauro F.
    Cancer Res; 1981 Apr 15; 41(4):1263-70. PubMed ID: 7214318
    [Abstract] [Full Text] [Related]

  • 44. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells.
    Manome Y, Weichselbaum RR, Kufe DW, Fine HA.
    Oncol Res; 1993 Apr 15; 5(3):139-44. PubMed ID: 8260751
    [Abstract] [Full Text] [Related]

  • 45. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Hapke DM, Stegmann AP, Mitchell BS.
    Cancer Res; 1996 May 15; 56(10):2343-7. PubMed ID: 8625309
    [Abstract] [Full Text] [Related]

  • 46. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin.
    Fornari FA, Jarvis WD, Grant S, Orr MS, Randolph JK, White FK, Mumaw VR, Lovings ET, Freeman RH, Gewirtz DA.
    Cell Growth Differ; 1994 Jul 15; 5(7):723-33. PubMed ID: 7947387
    [Abstract] [Full Text] [Related]

  • 47. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC, Jiang XP, Elliott RL, Head JF.
    Anticancer Res; 2001 Jul 15; 21(3B):1777-87. PubMed ID: 11497259
    [Abstract] [Full Text] [Related]

  • 48. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY, Shamsuddin AM.
    Anticancer Res; 1995 Jul 15; 15(6B):2479-87. PubMed ID: 8669811
    [Abstract] [Full Text] [Related]

  • 49. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil.
    Delvaeye M, Verovski V, De Neve W, Storme G.
    Anticancer Res; 1993 Jul 15; 13(5A):1533-8. PubMed ID: 8239532
    [Abstract] [Full Text] [Related]

  • 50. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
    Ross DD, Cuddy DP, Cohen N, Hensley DR.
    Cancer Chemother Pharmacol; 1992 Jul 15; 31(1):61-70. PubMed ID: 1458561
    [Abstract] [Full Text] [Related]

  • 51. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG, Gray JW, Folstad LJ.
    Cancer Res; 1982 Aug 15; 42(8):3125-31. PubMed ID: 7093956
    [Abstract] [Full Text] [Related]

  • 52. Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
    Carbone GM, Catapano CV, Fernandes DJ.
    Biochem Pharmacol; 2001 Jul 01; 62(1):101-10. PubMed ID: 11377401
    [Abstract] [Full Text] [Related]

  • 53. Activity and metabolism of 2-beta-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture.
    Earle MF, Glazer RI.
    Cancer Res; 1983 Jan 01; 43(1):133-7. PubMed ID: 6182988
    [Abstract] [Full Text] [Related]

  • 54. Biological and biochemical effects of 2'-azido-2'-deoxyarabinofuranosylcytosine on human tumor cells in vitro.
    Cheng YC, Derse D, Tan RS, Dutschman G, Bobek M, Schroeder A, Bloch A.
    Cancer Res; 1981 Aug 01; 41(8):3144-9. PubMed ID: 7248971
    [Abstract] [Full Text] [Related]

  • 55. Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.
    Glazer RI, Hartman KD, Richardson CL.
    Cancer Res; 1982 Jan 01; 42(1):117-21. PubMed ID: 7053840
    [Abstract] [Full Text] [Related]

  • 56. Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
    Raza A, Kuliczkowski K, Weidong G, Preisler HD.
    Med Oncol Tumor Pharmacother; 1984 Jan 01; 1(3):163-8. PubMed ID: 6544897
    [Abstract] [Full Text] [Related]

  • 57. Relationship between aberrant DNA replication and loss of cell viability in Chinese hamster ovary CHO-K1 cells.
    Woodcock DM, Adams JK, Cooper IA.
    Cancer Res; 1982 Nov 01; 42(11):4744-52. PubMed ID: 7127310
    [Abstract] [Full Text] [Related]

  • 58. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T, Iida H, Hori K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [Abstract] [Full Text] [Related]

  • 59. Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells.
    Grem JL, Politi PM, Berg SL, Benchekroun NM, Patel M, Balis FM, Sinha BK, Dahut W, Allegra CJ.
    Biochem Pharmacol; 1996 Jun 28; 51(12):1649-59. PubMed ID: 8687480
    [Abstract] [Full Text] [Related]

  • 60. Metabolism of cytosine arabinoside in Tetrahymena pyriformis.
    Benhura MA.
    Comp Biochem Physiol B; 1985 Jun 28; 80(4):821-5. PubMed ID: 3922672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.